ML-Driven Omics Risk Predictor for Occupational Safety
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
Dipartimento di Scienze biochimiche Alessandro Rossi Fanelli in Italy is seeking a researcher to advance ML methods for integrating omics and environmental data, identify biomarkers, and build predictive models for toxicological risk.
The role focuses on developing innovative ML approaches and applying statistical analysis, with emphasis on Python programming and data-driven research. Collaboration with cross-disciplinary teams is expected.
-
EHS Specialist
3 giorni fa
Roma, Lazio, Italia DAB Pumps Ltd Tempo pienoVerify your compatibility with this job adVerify your compatibility with this job adAbout DABAt DAB we are a global community of 1700 people. Our mission is to provide technological and sustainable solutions to handle water, which make us part of a needed change for our future. Our people culture is shaped by distributed leadership, embracing dynamic...
-
Roma, Lazio, Italia GSK Tempo pienoAt GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients,...
-
HSE Manager
1 settimana fa
roma, lazio, Italia Saipem Tempo pienoJoin Saipem and engineer a sustainable future. We are a global leader in engineering and construction for the energy and infrastructure sectors, delivering complex onshore and offshore projects worldwide. Driven by technological innovation as “One Company”, our 30,000 people from over 130 nationalities in more than 50 countries work every day to enable...
-
roma, lazio, Italia GSK Tempo pienoAt GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients,...
